PROSPECTIVE RANDOMIZED CLINICAL-TRIAL TO EVALUATE THE OPTIMAL DOSE OFI-131 FOR REMNANT ABLATION IN PATIENTS WITH DIFFERENTIATED THYROID-CARCINOMA - REPLY
C. Bal et al., PROSPECTIVE RANDOMIZED CLINICAL-TRIAL TO EVALUATE THE OPTIMAL DOSE OFI-131 FOR REMNANT ABLATION IN PATIENTS WITH DIFFERENTIATED THYROID-CARCINOMA - REPLY, Cancer, 79(1), 1997, pp. 190-191